Invitae Corporation Stock price

Equities

NVTA.Q

US46185L1035

Biotechnology & Medical Research

End-of-day quote OTC Markets 07:00:00 2024-03-17 pm EDT 5-day change 1st Jan Change
0.017 USD 0.00% Intraday chart for Invitae Corporation +6.25% -97.29%
Sales 2021 460M Sales 2022 516M Capitalization 452M
Net income 2021 -379M Net income 2022 -3.11B EV / Sales 2021 8.98 x
Net Debt 2021 679M Net Debt 2022 1.2B EV / Sales 2022 3.21 x
P/E ratio 2021
-8.5 x
P/E ratio 2022
-0.14 x
Employees 1,700
Yield 2021 *
-
Yield 2022
-
Free-Float 98.46%
More Fundamentals * Assessed data
Dynamic Chart
1 week+6.25%
Current month+40.50%
1 month-12.82%
3 months-97.11%
6 months-97.79%
Current year-97.29%
More quotes
1 week
0.02
Extreme 0.016
0.02
1 month
0.01
Extreme 0.01
0.03
Current year
0.01
Extreme 0.01
0.65
1 year
0.01
Extreme 0.01
1.67
3 years
0.01
Extreme 0.01
43.75
5 years
0.01
Extreme 0.01
61.59
10 years
0.01
Extreme 0.01
61.59
More quotes
Managers TitleAgeSince
Founder 66 10-01-12
Chief Executive Officer 63 20-06-28
Director of Finance/CFO - 23-10-01
Members of the board TitleAgeSince
Director/Board Member 67 15-11-03
Founder 66 10-01-12
Director/Board Member 62 10-08-31
More insiders
Date Price Change Volume
24-03-18 0.017 0.00% 1,192,449
24-03-15 0.017 +4.29% 987,271
24-03-14 0.0163 +0.62% 1,143,906
24-03-13 0.0162 -1.82% 1,619,789
24-03-12 0.0165 +3.13% 885,926

End-of-day quote OTC Markets, March 17, 2024

More quotes
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The Company also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The Company has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock
  2. Equities
  3. Stock Invitae Corporation - OTC Markets